In brief, E-values for SGLT2i + insulin vs control and GLP1-ra + insulin vs control analyses were generally greater than 1.5 (except for the diabetic retinopathy outcome in the SGLT2i + insulin vs control analysis which was 1.36). This evidence concerns the gene INS and diabetic retinopathy.